SynInnova Laboratories Inc.

SL-3452

Lenvatinib-d₄, >99% (HPLC)

Isotopic Purity :

98 atom % D

Synonyms : 4-(3-Chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide-d₄; E7080-d₄

Price and Availability
Pack Size	Price in USD	Quantity	Availability	Shipping Status
5MG	980.00	- +	In Stock	Estimated to Ship on 12.06.2024
10MG	1880.00	- +	In Stock	Estimated to Ship on 12.06.2024

Chemical Properties
Mol. Formula : C₂₁H₁₅D₄ClN₄O₄	Mol. Weight : 430.88
Appearance : Off-white solid	Melting Point : Not available
Solubility : DMSO (sparingly), MeOH (sparingly)
For Laboratory research use only, not for drug, household or other uses.

Applications : Lenvatinib-d4 is a deuterium labelled analog of Lenvatinib, which is an oral, multi-targeted tyrosine kinase inhibitor for the treatment of certain kinds of thyroid cancer.

References : Matsui J. et al.: Int. J. Cancer, 122 (3), 664-671, 2008; Matsui J. et al.: Clin Cancer Res., 14(17), 545, 2008; Glen H. et al.: BMC Cancer, 11, 309, 2011.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.

To receive price and delivery information on larger quantities, please complete the form below and we will respond promptly.

If you login prior to completion of the form, your contact information will automatically populate.

Your request for quote will also be accepted by e-mail at sales@syninnova.com or Fax: +1 780 485 2963.

Product ID : SL-3452

Product Name : Lenvatinib-d₄

Note : If you do not find your required compound in our catalogue, or not commercially available, please contact us, we will assist you to get your desired molecule. We only charge if we deliver to your satisfaction.

Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for COA. Thank you!

Site is under construction and it will coming soon. Please contact us at sales@syninnova.com for HNMR. Thank you!

Recently Viewed Products

SL-3452	Lenvatinib-d₄
SL-3458	Lenvatinib impurity 4
SI-1954	N-Cyclopropyl-4-[(5-iodo-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)methyl]benzene-1-sulfonamide
SI-467	3-(2-Hydroxyphenyl)-1-(3,4-dimethoxyphenyl)-1-propanone
SL-3455	Lenvatinib impurity 1
SI-4416	(4-Chlorophenyl)(3-hydroxyphenyl)methanone
SL-2417	Bupropion hydrochloride
SA-701	2-Aminobenzeneboronic acid pinacol ester
SL-2149	Erythro-dihydro bupropion
SI-1952	4-[(5-Iodo-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-methyl]-N-methylbenzene-1-sulfonamide
SA-465	4-Fluoro-2-(methoxycarbonylmethyl)benzeneboronic acid pinacol ester
SA-314	2-Chloro-5-fluorobenzeneboronic acid pinacol ester

Related Products

SL-3451	Lenvatinib-d₅
SL-3462	4-(4-Amino-3-chlorophenoxy)-7-methoxyquinoline-6-carboxamide
SL-3461	Lenvatinib impurity 10
SI-1591	4-Chloro-7-methoxyquinoline-6-carboxamide
SL-3460	Lenvatinib impurity 9
SL-3458	Lenvatinib impurity 4
SL-3454	Lenvatinib N-oxide
SI-1592	1-(2-Chloro-4-hydroxyphenyl)-3-cyclopropylurea
SL-3457	Lenvatinib impurity 3
SL-3452	Lenvatinib-d₄
SI-1588	Lenvatinib
SL-3455	Lenvatinib impurity 1

SL-3452

Lenvatinib-d4, >99% (HPLC)

Recently Viewed Products

Related Products

Lenvatinib-d₄, >99% (HPLC)